These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27749294)

  • 1. A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis.
    Yonekura H; Murayama N; Yamazaki H; Sobue K
    A A Case Rep; 2016 Dec; 7(11):243-246. PubMed ID: 27749294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.
    Kanaya A; Sato T; Fuse N; Yamaguchi H; Mano N; Yamauchi M
    J Anesth; 2018 Apr; 32(2):236-243. PubMed ID: 29468507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia.
    Loryan I; Lindqvist M; Johansson I; Hiratsuka M; van der Heiden I; van Schaik RH; Jakobsson J; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 2012 Apr; 68(4):397-406. PubMed ID: 22006347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.
    Mikstacki A; Zakerska-Banaszak O; Skrzypczak-Zielinska M; Tamowicz B; Prendecki M; Dorszewska J; Molinska-Glura M; Waszak M; Slomski R
    J Appl Genet; 2017 May; 58(2):213-220. PubMed ID: 27826892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment.
    Khan MS; Zetterlund EL; Gréen H; Oscarsson A; Zackrisson AL; Svanborg E; Lindholm ML; Persson H; Eintrei C
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):565-70. PubMed ID: 24891132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece.
    Mastrogianni O; Gbandi E; Orphanidis A; Raikos N; Goutziomitrou E; Kolibianakis EM; Tarlatzis BC; Goulas A
    Drug Metab Pharmacokinet; 2014; 29(2):215-8. PubMed ID: 24153159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age.
    Kansaku F; Kumai T; Sasaki K; Yokozuka M; Shimizu M; Tateda T; Murayama N; Kobayashi S; Yamazaki H
    Drug Metab Pharmacokinet; 2011; 26(5):532-7. PubMed ID: 21869535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).
    Takahashi H; Maruo Y; Mori A; Iwai M; Sato H; Takeuchi Y
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):131-6. PubMed ID: 18816295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of potential genetic determinants of propofol requirements and recovery from anaesthesia.
    Iohom G; Ni Chonghaile M; O'Brien JK; Cunningham AJ; Fitzgerald DF; Shields DC
    Eur J Anaesthesiol; 2007 Nov; 24(11):912-9. PubMed ID: 17555608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma concentration of propofol was 4.4 microg x ml(-1), 4.5 hours after completion of its administration].
    Kawaguchi Y; Ishihara H; Kushikata T; Kitayama M; Hirota K
    Masui; 2010 Dec; 59(12):1510-3. PubMed ID: 21229693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability.
    Mourão AL; de Abreu FG; Fiegenbaum M
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):511-5. PubMed ID: 26141406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed emergence from propofol, nitrous oxide and oxygen anesthesia--a case report].
    Koitabashi T; Satoh N; Takino Y
    Masui; 1997 Jul; 46(7):975-7. PubMed ID: 9251517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
    Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L
    Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using of chromatographical methods to study stability, pharmacokinetics and metabolism of propofol (review)].
    Adeishvili-Anguladze LV; Makharadze RV; Kurtsikidze MSh; Abuladze NB; Gabuniia KU
    Georgian Med News; 2009 May; (170):95-100. PubMed ID: 19556652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the ke0 and what does it tell me about propofol?
    Cortínez LI
    Anaesthesia; 2014 May; 69(5):399-402. PubMed ID: 24738794
    [No Abstract]   [Full Text] [Related]  

  • 17. Onset and offset pharmacodynamics of propofol.
    O'Halloran PL; Hosseini-Yeganeh M; McBride LJ; Ramzan I
    Pharmazie; 2004 Jan; 59(1):76-7. PubMed ID: 14964429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration.
    Fujita A; Hayamizu K; Yoshihara T; Zaitsu M; Shiraishi F; Arima H; Matsuo K; Shiokawa K; Setoguchi H; Sasaguri T
    JA Clin Rep; 2018 Aug; 4(1):59. PubMed ID: 32025958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between
    Wang YB; Zhang RZ; Huang SH; Wang SB; Xie JQ
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28899924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of
    Alrabayah M; Massad IM; Imraish A; Jarrar Y; Massad F; Guzu H; Abufares B; Al-Oran A; Alkharabsheh MM; Haroon N; Ismail MA; Qaqish B; Zihlif M
    Curr Drug Metab; 2023; 23(14):1156-1161. PubMed ID: 36717987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.